Treatment of membranous nephropathy

Nephrology Dialysis Transplantation

Volumn 16, Issue SUPPL. 5, 2001, Pages 8-10

  Ponticelli, Claudio ^a,b   Passerini, Patrizia ^a  

^a MAGGIORE HOSPITAL   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Chlorambucil; Corticosteroid; Cyclophosphamide; Cyclosporine; Membranous nephropathy

Indexed keywords

CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC AGENT; METHYLPREDNISOLONE; PREDNISONE; STEROID;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FOLLOW UP; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; META ANALYSIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; REMISSION; SURVIVAL RATE;

EID: 0034864778     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.suppl_5.8     Document Type: Article

References (32)

1. Membranous nephropathy
2. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes
3. Significance of tubulointerstitial lesions in biopsy specimens of glomerulonephritic patients
4. The increased risk of coronary heart disease associated with nephrotic syndrome
5. The natural history of membranous nephropathy in the west of Scotland
6. Membranous nephropathy and thromboembolism: Is prophylactic anticoagulation warranted
7. Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy
8. Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria
9. A review of therapeutic studies of idiopathic membranous glomerulopathy
10. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy
11. Management of idiopathic membranous nephropathy: Evidence-based recommendations
12. A prospective randomized trial in the use of cyclophosphamide, dipyridamole and warfarin in membranous and mesangiocapillary glomerulonephritis
13. Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis
14. Traitement par le chlorambucil et l' azathioprine dans les glomerulonephrites primitives: Resultats d'une étude controlée
15. A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis
16. Controlled trial of cyclophosphamide in idiopathic membranous nephropathy
17. Treatment of progressive membranous glomerulopathy. A randomized trial comparing cyclosphosphamide and corticosteroids with corticosteroids alone
18. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy
19. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy
20. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy
21. Therapy for idiopathic membranous nephropathy: Tailoring the choice by decision analysis
22. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy
23. Idiopathic membranous nephropathy in the elderly
24. Outcome of membranous glomerulonephritis in the elderly
25. Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function
26. Low-dose prednisolone chlorambucil therapy in patients with severe membranous glomerulonephritis
27. Preserving renal function in patients with membranous nephropathy: Daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide
28. Antiproteinuric and immunological effects of cyclosporin A in the treatment of glomerular diseases
29. Short-term responsiveness of membranous glomerulopathy to cyclosporine
30. Long-term cyclosporin A therapy for severe idiopathic membranous nephropathy
31. A controlled trial of cyclosporine in patients with progressive membranous nephropathy
32. Treatment of membranous glomerulopathy with cyclosporin A: How much patience is required?